Phathom Pharmaceuticals, Inc. (PHAT) Profit Margin
Phathom Pharmaceuticals, Inc. (PHAT) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | -29558.94% |
| 2024-12-31 | -605.09% |
| 2025-12-31 | -126.35% |
How PHAT compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| AXSM | Axsome Therapeutics Inc. | -28.69% |
| IONS | Ionis Pharmaceuticals Inc. | -40.41% |
| QDEL | QuidelOrtho Corp Com | -41.45% |
| MYGN | Myriad Genetics Inc. | -44.38% |
| IOVA | Iovance Biotherapeutics Inc. | -148.39% |
These are five companies in the same sector as PHAT with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Phathom Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("PHAT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PHAT | $9.39 | -1.88% | 0.88M |
| 3 | ||||
| 4 | ||||
| 5 |